All In MedTech

Device Trial Radar · NCT05523622

Comparison of Intraocular Pressure Measurement With the Novel TonoVera Device With Other Commonly Used Devices

Last checked: Nov 19, 2026Latest source record: May 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Aug 1, 2022

Primary completion

Dec 31, 2027

Study completion Dec 31, 2027

Sponsor

Lead sponsor
State University of New York at BuffaloAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Reichert, Inc.
First posted
Aug 31, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

We are testing the accuracy of Reichert's Tono-Vera tonometer by comparing measurements of IOP with this device and measurements with other commonly-used tonometers, including Goldmann Applanation and iCare.

Conditions

  • Glaucoma

Interventions

  • Tono-Vera tonometerDevice

    The tonometer measures intraocular pressure with a small rebound probe, similar to those used with other tonometers currently on the market, such as the iCare.

  • Goldman Applanation TonometryDevice

    This is the current gold standard for measuring eye pressure.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Intraocular PressureTime frame: Baseline only

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Ross Eye Institute

    Buffalo, New York · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.